N/A
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Signed informed consent Age * 18 years
Exclusion criteria
Exclusion criteria: Symptoms relating to respiratory or cardiovascular disease History of pneumothorax or family history of primary pneumothorax Obesity (BMI > 30) Known pregnancy Contraindications for the placement of a nasogastric tube (Upper airwau/esophageal/gastric/mouth or face pathology, nasal bleeding within the last 2 weeks or use of anticoagulants) Contraindictions for MRI (Electrical/metallic implants, claustrophobia, history in metalworking)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The first main parameter is the change in the position of the diaphragm during different PEEP levels, as measured with both ultrasound and MRI. The second parameter is the changes in neuro-mechanical efficiency of the diaphragm (ratio between pressure and electrical muscle activity) during different PEEP levels, as measured with a nasogastric catheter. Furthermore, twitch transdiaphragmatic pressures during different PEEP levels, as measured with magnetic stimulation of the phrenic nerves, will be monitored. At last, changes of the diaphragm*s shape and length during different PEEP levels, as measured with MRI will be used. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary study parameters is the difference between diaphragm parameters obtained by ultrasound and parameters obtained by MRI. | — |
Countries
Netherlands